Characterization and Clinical Management of Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) is a particular phenotype of non-ischemic systolic heart failure, frequently recognizing a genetic background and affecting relatively young patients with few comorbidities. Nowadays, long-term survival of DCM patients has been markedly improved due to an early diagnosis...

Descrición completa

Gardado en:
Detalles Bibliográficos
Formato: Online
Idioma:inglés
Publicado: MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:
Acceso en liña:ONIX_20210501_9783039437610_26
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
_version_ 1869515879546355712
collection Directory of Open Access Books
description Dilated cardiomyopathy (DCM) is a particular phenotype of non-ischemic systolic heart failure, frequently recognizing a genetic background and affecting relatively young patients with few comorbidities. Nowadays, long-term survival of DCM patients has been markedly improved due to an early diagnosis and uninterrupted and tailored follow-up under constant optimal medical and non-pharmacological evidence-based treatments. Nevertheless, DCM is still one of the most common causes of heart transplantation in the western world. Clinical management requires an integrated and systematic use of diagnostic tools and a deeper investigation of the basic mechanisms underlying the disease. However, several emerging issues remain debated. Specifically, the genotype–phenotype correlation, the role of advanced imaging techniques and genetic testing, the lack of appropriate risk stratification models, the need for a multiparametric and multidisciplinary approach for device implantation, and a continuous reclassification of the disease during follow-up remain challenging issues in clinical practice. Therefore, the aim of this Special Issue is to shed the light on the most recent advancements in characterization and clinical management of DCM in order to unveil the conundrum of this particular disease.
format Online
id doab-20.500.12854ir-68283
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-682832024-03-30T23:21:48Z Characterization and Clinical Management of Dilated Cardiomyopathy Merlo, Marco SCN5A cardiac sodium channel cardiac channelopathy dilated cardiomyopathy precision medicine arrhythmias atrial fibrillation cardiomyopathy heart failure supraventricular arrhythmia systolic dysfunction tachycardiomyopathy ventricular arrhythmia left atrial strain cardiac resynchronization therapy muscular dystrophy calcium heart gene therapy phospholamban Serca2a mdx oxidative stress membrane stabilization left ventricular noncompaction congenital heart disease congestive heart failure non-ischemic cardiomyopathy genetics desmin mitochondrial dysfunction myopathy whole exome sequencing laminopathy LMNA biomarkers troponin T NT-proBNP malignant ventricular arrhythmia arrhythmic risk stratification DNA methylation alternative splicing epigenetics nonischemic dilated cardiomyopathy cardiac magnetic resonance imaging late gadolinium enhancement long axis strain left ventricle sphericity index major adverse cardiovascular events sex differences left ventricular reverse remodelling long-term outcomes left ventricle non-compaction cardiomyopathy cardiac magnetic resonance titin RNA binding motif protein 20 (RBM20) sarcomere diastolic dysfunction phosphorylation non-sense mRNA decay mammalian target of rapamycin (mTOR) complex-1 duchenne muscular distrophy n/a thema EDItEUR::M Medicine and Nursing Dilated cardiomyopathy (DCM) is a particular phenotype of non-ischemic systolic heart failure, frequently recognizing a genetic background and affecting relatively young patients with few comorbidities. Nowadays, long-term survival of DCM patients has been markedly improved due to an early diagnosis and uninterrupted and tailored follow-up under constant optimal medical and non-pharmacological evidence-based treatments. Nevertheless, DCM is still one of the most common causes of heart transplantation in the western world. Clinical management requires an integrated and systematic use of diagnostic tools and a deeper investigation of the basic mechanisms underlying the disease. However, several emerging issues remain debated. Specifically, the genotype–phenotype correlation, the role of advanced imaging techniques and genetic testing, the lack of appropriate risk stratification models, the need for a multiparametric and multidisciplinary approach for device implantation, and a continuous reclassification of the disease during follow-up remain challenging issues in clinical practice. Therefore, the aim of this Special Issue is to shed the light on the most recent advancements in characterization and clinical management of DCM in order to unveil the conundrum of this particular disease. 2021-05-01T15:06:06Z 2021-05-01T15:06:06Z 2021 book ONIX_20210501_9783039437610_26 9783039437610 9783039437627 https://directory.doabooks.org/handle/20.500.12854/68283 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/3292 https://mdpi.com/books/pdfview/book/3292 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03943-762-7 10.3390/books978-3-03943-762-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039437610 9783039437627 232 Basel, Switzerland open access
spellingShingle SCN5A
cardiac sodium channel
cardiac channelopathy
dilated cardiomyopathy
precision medicine
arrhythmias
atrial fibrillation
cardiomyopathy
heart failure
supraventricular arrhythmia
systolic dysfunction
tachycardiomyopathy
ventricular arrhythmia
left atrial strain
cardiac resynchronization therapy
muscular dystrophy
calcium
heart
gene therapy
phospholamban
Serca2a
mdx
oxidative stress
membrane stabilization
left ventricular noncompaction
congenital heart disease
congestive heart failure
non-ischemic cardiomyopathy
genetics
desmin
mitochondrial dysfunction
myopathy
whole exome sequencing
laminopathy
LMNA
biomarkers
troponin T
NT-proBNP
malignant ventricular arrhythmia
arrhythmic risk stratification
DNA methylation
alternative splicing
epigenetics
nonischemic dilated cardiomyopathy
cardiac magnetic resonance imaging
late gadolinium enhancement
long axis strain
left ventricle sphericity index
major adverse cardiovascular events
sex differences
left ventricular reverse remodelling
long-term outcomes
left ventricle non-compaction cardiomyopathy
cardiac magnetic resonance
titin
RNA binding motif protein 20 (RBM20)
sarcomere
diastolic dysfunction
phosphorylation
non-sense mRNA decay
mammalian target of rapamycin (mTOR) complex-1
duchenne muscular distrophy
n/a
thema EDItEUR::M Medicine and Nursing
Characterization and Clinical Management of Dilated Cardiomyopathy
title Characterization and Clinical Management of Dilated Cardiomyopathy
title_full Characterization and Clinical Management of Dilated Cardiomyopathy
title_fullStr Characterization and Clinical Management of Dilated Cardiomyopathy
title_full_unstemmed Characterization and Clinical Management of Dilated Cardiomyopathy
title_short Characterization and Clinical Management of Dilated Cardiomyopathy
title_sort characterization and clinical management of dilated cardiomyopathy
topic SCN5A
cardiac sodium channel
cardiac channelopathy
dilated cardiomyopathy
precision medicine
arrhythmias
atrial fibrillation
cardiomyopathy
heart failure
supraventricular arrhythmia
systolic dysfunction
tachycardiomyopathy
ventricular arrhythmia
left atrial strain
cardiac resynchronization therapy
muscular dystrophy
calcium
heart
gene therapy
phospholamban
Serca2a
mdx
oxidative stress
membrane stabilization
left ventricular noncompaction
congenital heart disease
congestive heart failure
non-ischemic cardiomyopathy
genetics
desmin
mitochondrial dysfunction
myopathy
whole exome sequencing
laminopathy
LMNA
biomarkers
troponin T
NT-proBNP
malignant ventricular arrhythmia
arrhythmic risk stratification
DNA methylation
alternative splicing
epigenetics
nonischemic dilated cardiomyopathy
cardiac magnetic resonance imaging
late gadolinium enhancement
long axis strain
left ventricle sphericity index
major adverse cardiovascular events
sex differences
left ventricular reverse remodelling
long-term outcomes
left ventricle non-compaction cardiomyopathy
cardiac magnetic resonance
titin
RNA binding motif protein 20 (RBM20)
sarcomere
diastolic dysfunction
phosphorylation
non-sense mRNA decay
mammalian target of rapamycin (mTOR) complex-1
duchenne muscular distrophy
n/a
thema EDItEUR::M Medicine and Nursing
topic_facet SCN5A
cardiac sodium channel
cardiac channelopathy
dilated cardiomyopathy
precision medicine
arrhythmias
atrial fibrillation
cardiomyopathy
heart failure
supraventricular arrhythmia
systolic dysfunction
tachycardiomyopathy
ventricular arrhythmia
left atrial strain
cardiac resynchronization therapy
muscular dystrophy
calcium
heart
gene therapy
phospholamban
Serca2a
mdx
oxidative stress
membrane stabilization
left ventricular noncompaction
congenital heart disease
congestive heart failure
non-ischemic cardiomyopathy
genetics
desmin
mitochondrial dysfunction
myopathy
whole exome sequencing
laminopathy
LMNA
biomarkers
troponin T
NT-proBNP
malignant ventricular arrhythmia
arrhythmic risk stratification
DNA methylation
alternative splicing
epigenetics
nonischemic dilated cardiomyopathy
cardiac magnetic resonance imaging
late gadolinium enhancement
long axis strain
left ventricle sphericity index
major adverse cardiovascular events
sex differences
left ventricular reverse remodelling
long-term outcomes
left ventricle non-compaction cardiomyopathy
cardiac magnetic resonance
titin
RNA binding motif protein 20 (RBM20)
sarcomere
diastolic dysfunction
phosphorylation
non-sense mRNA decay
mammalian target of rapamycin (mTOR) complex-1
duchenne muscular distrophy
n/a
thema EDItEUR::M Medicine and Nursing
url ONIX_20210501_9783039437610_26